BOSTON, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Life Biosciences, Inc., (“Life Bio”) a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, ...

Arteritic anterior ischemic optic neuropathy (AAION) is a common cause of vision loss in patients with temporal arteritis. 3 Thus, temporal artery biopsy should be used to rule out temporal arteritis ...

Research shows semaglutide users face a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) compared to users of other medications for diabetes and obesity ...

Use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) may be linked with an increased risk of the second most common form of optic neuropathy, a retrospective study suggested. Over a mean ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a Maryland man who developed non-arteritic anterior ischemic optic neuropathy ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults prescribed semaglutide were more likely to ...

The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which the optic nerve is damaged by a sudden ...

It is recognized that standard interferon therapy can rarely cause ocular toxicity, including retinopathy and optic neuropathy, 1 but the frequency and severity of adverse effects of the pegylated ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

A 53-year-old man presented to the hospital after losing vision in his left eye. He explained that he had been given his second dose of Pfizer's COVID vaccine (Comirnaty) 10 days previously. He said ...